Author’s response to “Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?”

被引：0
|
作者：
Louis Monnier
机构：
[1] Lapeyronie Hospital,Department of Metabolic Diseases
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2007年 / 3卷 / 5期
关键词：
D O I：
10.1038/ncpendmet0507
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：E2 / E2
相关论文
共 50 条
  • [1] Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
    Louis Monnier
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 332 - 333
  • [2] Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
    Monnier, Louis
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (04): : 332 - 333
  • [3] Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
    Steve V Edelman
    Satish Garg
    Orville G Kolterman
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (5): : E1 - E1
  • [4] Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus
    Nogid, Anna
    Pham, David Q.
    [J]. PHARMACOTHERAPY, 2006, 26 (11): : 1626 - 1640
  • [5] Diabetes Distress and Its Association with Clinical Outcomes in Patients with Type 2 Diabetes Treated with Pramlintide as an Adjunct to Insulin Therapy
    Peyrot, Mark
    Rubin, Richard R.
    Polonsky, William H.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (06) : 461 - 466
  • [6] Effects of six months administration of pramlintide as an adjunct to insulin therapy on metabolic control in people with type 1 diabetes
    Fineman, M
    Bahner, A
    Gottlieb, A
    Kolterman, OG
    [J]. DIABETES, 1999, 48 : A113 - A114
  • [7] Pramlintide (human amylin analogue) as an adjunct to insulin therapy in patients with type 1 diabetes improved glycemic control over 2 years
    Kolterman, OG
    Bahner, A
    Gottlieb, A
    Fineman, M
    [J]. DIABETES, 1999, 48 : A104 - A105
  • [8] Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis
    Qiao, Yong-Chao
    Ling, Wei
    Pan, Yan-Hong
    Chen, Yin-Ling
    Zhou, Dan
    Huang, Yan-Mei
    Zhang, Xiao-Xi
    Zhao, Hai-Lu
    [J]. ONCOTARGET, 2017, 8 (39) : 66504 - 66515
  • [9] Pramlintide as an adjunct to insulin glargine reduced A1C and body weight in patients with type 2 diabetes
    Frias, Juan
    Bei, Zhang
    Darsow, Tamara
    [J]. DIABETES, 2006, 55 : A112 - A112
  • [10] Pramlintide, as an adjunct to premixed insulin, reduced A1C and body weight in patients with type 2 diabetes
    Lorenzi, Gayle
    Zhang, Bei
    Darsow, Tamara
    Maier, Holly
    Wilhelm, Ken
    [J]. DIABETES, 2008, 57 : A585 - A585
12345